Texas Permanent School Fund Corp Sells 5,376 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Texas Permanent School Fund Corp lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 20.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 21,485 shares of the company’s stock after selling 5,376 shares during the period. Texas Permanent School Fund Corp’s holdings in Henry Schein were worth $1,377,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Quest Partners LLC bought a new stake in shares of Henry Schein during the second quarter valued at approximately $177,000. Acadian Asset Management LLC raised its stake in Henry Schein by 10.2% in the second quarter. Acadian Asset Management LLC now owns 3,757 shares of the company’s stock worth $240,000 after buying an additional 348 shares in the last quarter. National Bank of Canada FI raised its stake in Henry Schein by 15.5% in the second quarter. National Bank of Canada FI now owns 43,769 shares of the company’s stock worth $2,850,000 after buying an additional 5,860 shares in the last quarter. Versor Investments LP bought a new position in Henry Schein in the second quarter worth approximately $527,000. Finally, Tandem Investment Advisors Inc. raised its stake in Henry Schein by 2.5% in the second quarter. Tandem Investment Advisors Inc. now owns 58,083 shares of the company’s stock worth $3,723,000 after buying an additional 1,390 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Insider Activity

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

Shares of HSIC opened at $72.54 on Friday. The firm has a market capitalization of $9.29 billion, a PE ratio of 24.51, a price-to-earnings-growth ratio of 1.88 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company’s fifty day moving average price is $69.77 and its 200-day moving average price is $70.42.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business’s quarterly revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.31 earnings per share. On average, equities research analysts predict that Henry Schein, Inc. will post 4.75 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Robert W. Baird reduced their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Piper Sandler reissued an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a research note on Friday, June 21st. Barrington Research reduced their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Finally, JPMorgan Chase & Co. cut their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Henry Schein presently has a consensus rating of “Hold” and an average price target of $77.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.